Melinta Rips Investor Challenge To Its Confirmed Ch. 11 Plan
Law360 (August 27, 2020, 6:31 PM EDT) -- Antibiotic developer Melinta Therapeutics has told the Delaware bankruptcy court that it should reject attempts by former stockholders to revisit aspects of the company's already approved Chapter 11 plan, saying they are raising issues that were already addressed or should have been asserted earlier.
In an objection filed Wednesday with U.S. Bankruptcy Judge Laurie Selber Silverstein, Melinta also argued that a pending appeal of the plan's confirmation in Delaware federal court bars the bankruptcy court from acting on a series of requests from a group of former shareholders. The ex-shareholders have filed various motions over the past few months, seeking to...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!